journal article·2021-12-28

Tailoring Chemoimmunostimulant Bioscaffolds for Inhibiting Tumor Growth and Metastasis after Incomplete Microwave Ablation

Yuting Shen, Liang Chen, Xin Guan, Xiaoxia Han, Xiaowan Bo, Shaoyue Li, Liping Sun, Yu Chen, Wenwen Yue, Huixiong Xu

ACS Nano· Volume 15· Issue 12
Publisher page

Abstract

Microwave ablation has attracted the most attention as a locoregional therapeutic method for solid neoplasms. However, the high incidence of incomplete ablation that could promote the rapid cancer progression still remains a challenge in clinic. Herein, we found that the high invasiveness of residual tumor following incomplete microwave ablation (iMWA) is mainly due to the myeloid cell-mediated immunosuppression. Accordingly, we develop a biohydrogel scaffold-enabled chemoimmunotherapeutic strategy by targeting myeloid cells with a phosphoinositide 3-kinase γ (PI3Kγ) inhibitor (IPI549) to synergize with immunostimulatory chemotherapy (Oxaliplatin, OX) for post-ablative cancer therapy. With several tumor mouse models, we reveal that OX&IPI549@Gel-based localized chemoimmunotherapy can substantially suppress the growth of tumor post-iMWA, simultaneously evoke robust systemic anticancer immunity to inhibit metastatic spread, and offer strong long-term immunological memory functions against tumor rechallenge. Besides, this work proposes a potential opportunity for precision medicine by utilizing a mechanism-based rationale to the adoption of our pre-existing arsenal of anticancer immunotherapeutic schedule.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer Research and Treatments · Cancer Cells and Metastasis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center of Minimally Invasive Treatment for Tumor, Department of Medical Ultrasound, Shanghai Tenth People’s Hospital; Ultrasound Research and Education Institute, Clinical Research Center for Interventional Medicine, School of Medicine, Tongji University; Shanghai Engineering Research Center of Ultrasound Diagnosis and Treatment; National Clinical Research Center for Interventional Medicine, Shanghai 200072, P. R. China

Department of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, P. R. China

School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China

Funding

Science and Technology Commission of Shanghai Municipality · Shanghai Municipal Health Commission · National Natural Science Foundation of China · Shanghai Tenth People???s Hospital Climbing Talent Project · Shanghai Rising-Star Program · Shanghai Pujiang Program

References (58)

Show source-provided references
1. 10.1038/nrclinonc.2014.23710.1038/nrclinonc.2014.237 ↗
2. 10.1200/JCO.2012.46.189710.1200/JCO.2012.46.1897 ↗
3. 10.1016/j.juro.2009.07.06410.1016/j.juro.2009.07.064 ↗
4. 10.1016/j.jhep.2010.04.04010.1016/j.jhep.2010.04.040 ↗
5. 10.1148/radiol.201716294310.1148/radiol.2017162943 ↗
6. 10.1097/SLA.000000000000347410.1097/SLA.0000000000003474 ↗
7. 10.1016/j.jhep.2019.01.02710.1016/j.jhep.2019.01.027 ↗
8. 10.1038/nrc367210.1038/nrc3672 ↗
9. 10.1038/d41586-018-05312-910.1038/d41586-018-05312-9 ↗
10. 10.1038/nature1067310.1038/nature10673 ↗
11. 10.1126/sciadv.aaz420410.1126/sciadv.aaz4204 ↗
12. 10.1016/j.immuni.2013.03.00310.1016/j.immuni.2013.03.003 ↗
13. 10.1038/nri.2016.10710.1038/nri.2016.107 ↗
14. 10.1002/adhm.20210119910.1002/adhm.202101199 ↗
15. 10.1126/scitranslmed.aag294210.1126/scitranslmed.aag2942 ↗
16. 10.1038/natrevmats.2015.1210.1038/natrevmats.2015.12 ↗
17. 10.1038/natrevmats.2016.4110.1038/natrevmats.2016.41 ↗
18. 10.1038/nbt0616-666e10.1038/nbt0616-666e ↗
19. 10.1126/scitranslmed.aan368210.1126/scitranslmed.aan3682 ↗
20. 10.1016/j.ccr.2011.04.01610.1016/j.ccr.2011.04.016 ↗
21. 10.1038/nature2102610.1038/nature21026 ↗
22. 10.1021/acsmedchemlett.6b0023810.1021/acsmedchemlett.6b00238 ↗
23. 10.1038/nature2055410.1038/nature20554 ↗
24. 10.1126/science.123222710.1126/science.1232227 ↗
25. 10.1038/s41590-019-0514-y10.1038/s41590-019-0514-y ↗
26. 10.1038/nature1428210.1038/nature14282 ↗
27. 10.1146/annurev-cellbio-111315-12534110.1146/annurev-cellbio-111315-125341 ↗
28. 10.1007/s10555-016-9637-x10.1007/s10555-016-9637-x ↗
29. 10.1038/s41467-020-18973-w10.1038/s41467-020-18973-w ↗
30. 10.1038/ng198710.1038/ng1987 ↗
31. 10.1126/science.aaf440510.1126/science.aaf4405 ↗
32. 10.1182/blood.V75.5.1037.103710.1182/blood.V75.5.1037.1037 ↗
33. 10.1073/pnas.091137810710.1073/pnas.0911378107 ↗
34. 10.1038/nature0634810.1038/nature06348 ↗
35. 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G ↗
36. 10.1016/j.ccell.2016.07.00910.1016/j.ccell.2016.07.009 ↗
37. 10.1016/j.it.2019.02.00310.1016/j.it.2019.02.003 ↗
38. 10.1038/ni.270310.1038/ni.2703 ↗
39. 10.1021/acs.accounts.0c0033910.1021/acs.accounts.0c00339 ↗
40. 10.1126/scitranslmed.aar191610.1126/scitranslmed.aar1916 ↗
41. 10.1038/s41573-018-0006-z10.1038/s41573-018-0006-z ↗
42. 10.1038/s41563-018-0147-910.1038/s41563-018-0147-9 ↗
43. 10.1016/j.jconrel.2019.05.00810.1016/j.jconrel.2019.05.008 ↗
44. 10.1126/sciadv.abb463910.1126/sciadv.abb4639 ↗
45. 10.1002/bit.2559810.1002/bit.25598 ↗
46. 10.3390/ijms2113461610.3390/ijms21134616 ↗
47. 10.1038/s41467-020-18493-710.1038/s41467-020-18493-7 ↗
48. 10.1148/radiol.221100162410.1148/radiol.2211001624 ↗
49. 10.1021/acs.nanolett.7b0321810.1021/acs.nanolett.7b03218 ↗
50. 10.1016/j.cell.2018.06.01710.1016/j.cell.2018.06.017 ↗
51. 10.1038/ncomms730110.1038/ncomms7301 ↗
52. 10.1038/s41590-020-0791-510.1038/s41590-020-0791-5 ↗
53. 10.1038/nri330710.1038/nri3307 ↗
54. 10.21037/cco.2019.11.0310.21037/cco.2019.11.03 ↗
55. 10.1016/j.jhep.2011.12.00110.1016/j.jhep.2011.12.001 ↗
56. 10.1001/jamanetworkopen.2019.970210.1001/jamanetworkopen.2019.9702 ↗
57. 10.1038/nrurol.2017.14310.1038/nrurol.2017.143 ↗
58. 10.1021/acs.nanolett.1c0000910.1021/acs.nanolett.1c00009 ↗